收藏切换
Study on active ingredients and molecular mechanism of keluoxin in treatment of diabetic kidney disease based on network pharmacology and molecular docking
收藏切换
Huimin ZHAO, Jiahui XU, Qingguang CHEN, Hao LU*
World Clinical Drug | 2023, 44(5) : 468 - 476
Less
收藏切换
World Clinical Drug | 2023, 44(5): 468-476
• Article •
Study on active ingredients and molecular mechanism of keluoxin in treatment of diabetic kidney disease based on network pharmacology and molecular docking
Full
Huimin ZHAO, Jiahui XU, Qingguang CHEN, Hao LU*
Affiliations
  • Department of Endocrinology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
Published: 2023-05-10 doi: 10.13683/j.wph.2023.05.011
Outline
收藏切换
Objective

To explore the key active ingredients and molecular mechanisms of keluoxin in the treatment of diabetic nephropathy (DN) by network pharmacology and molecular docking methods.

Methods

The active constituents and their corresponding targets of keluoxin were obtained through the pharmacological analysis platform of traditional Chinese medicine. Disease targets related to DN were obtained by GeneCards and OMIM databases, and drug targets of DN were screened. Cytoscape software was used to map active ingredient-target network and protein-protein interaction network. Gene ontology and functional enrichment analysis of Kyoto gene and genome database were conducted on the target. Autodock Vina software was used to verify the molecular docking between the main active ingredients of keluoxin and the key targets.

Results

Keluoxin can exert its therapeutic effect on DN by acting on 97 target genes through 57 active ingredients. There were 9 main active ingredients, which can regulate signaling pathway by influencing oxidative stress, inflammatory response, hypoxia response, metabolic regulation and cell apoptosis. Molecular docking results showed that quercetin, luteolin and calycoflavone had the strongest affinity to the key targets, which may be the core acting molecules in keluoxine.

Conclusion

The potential mechanism of keluoxin in the treatment of DN is multi-target and multi-pathway, among which quercetin, luteolin and calycoflavone may be the core molecules in keluoxin.

network pharmacology  /  molecular docking  /  keluoxin  /  diabetic nephropathy  /  molecular mechanism
赵慧敏, 许嘉慧, 陈清光, 陆灏. 基于网络药理学和分子对接技术探讨渴络欣治疗糖尿病肾病活性成分及作用机制. 世界临床药物, 2023 , 44 (5) : 468 -476 . DOI: 10.13683/j.wph.2023.05.011
Huimin ZHAO, Jiahui XU, Qingguang CHEN, Hao LU. Study on active ingredients and molecular mechanism of keluoxin in treatment of diabetic kidney disease based on network pharmacology and molecular docking[J]. World Clinical Drug, 2023 , 44 (5) : 468 -476 . DOI: 10.13683/j.wph.2023.05.011
Year 2023 volume 44 Issue 5
7
0
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2023.05.011
  • Receive Date:2023-02-25
  • Online Date:2026-11-18
  • Published:2023-05-10
Article Data
Affiliations
History
  • Received:2023-02-25
Funding
Affiliations
    Department of Endocrinology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2023.05.011
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT